| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/11/2008 | US7449554 Antibodies against the PRO4977 polypeptides |
| 11/11/2008 | US7449553 Lipid engineering for analyzing a structure, or functions of a ceramide, diseases associated with the ceramide metabolism; controlling an amount of ceramide in a cell |
| 11/11/2008 | US7449551 PRO211 polypeptides |
| 11/11/2008 | US7449549 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 11/11/2008 | US7449548 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 11/11/2008 | US7449545 Antimicrobial bolisin peptides |
| 11/11/2008 | US7449543 Binds to the polypeptide g34872 or binds to a calcium/calmodulin-dependent kinase II; treatment or diagnosis of central nervous system and bipolar disorders |
| 11/11/2008 | US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 11/11/2008 | US7449449 Providing microprojectiles carrying polynucleic acid sequences; accelerating the microprojectiles at the preselected-cells, with the microprojectiles contacting cells to penetrate vertebrate cells and deposit polynucleic acid |
| 11/11/2008 | US7449335 Precise cutting |
| 11/11/2008 | US7449326 Detecting nucleotide sequences in sample; adhere and immbolize pure nucleotide sequences to support, elute nucleotide sequences, amplify recovered nucleotide sequences, detect amplified products |
| 11/11/2008 | US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus) |
| 11/11/2008 | US7449322 Avian leukosis viruses and polypeptide display |
| 11/11/2008 | US7449320 Pullulanase for use in saccharfication of stsrches |
| 11/11/2008 | US7449319 polypeptides having hydrolase enzyme activity, useful in the conversion of cellulose to sugars and/or ethanol |
| 11/11/2008 | US7449318 Bacillus mHKcel cellulase |
| 11/11/2008 | US7449317 Phytase enzymes, nucleic acid sequences encoding phytase enzymes and vectors and host cells incorporating same |
| 11/11/2008 | US7449316 UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, α4Gal-T1 |
| 11/11/2008 | US7449314 Killing bacterial contaminats in mammalian milk via controlled heating of liquids |
| 11/11/2008 | US7449312 amixture of sodium pyrophosphate and pyrophosphatase, used for DNA sequencing |
| 11/11/2008 | US7449309 administering antibodies or fragments that binds to kit proteins (glycoprotein receptor protein-tyrosine kinase), to inhibit the kinase enzymatic reactions and to inhibit the stem cell factor signal transduction; treatment of skin disorders, asthma, inflammation, anaphylaxis, bronchospasm and tumors |
| 11/11/2008 | US7449308 Glycosylation; genetic engineering; Dna libraries |
| 11/11/2008 | US7449303 Use of JAG2 expression in diagnosis of plasma cell disorders |
| 11/11/2008 | US7449301 Pharmaceutical composition and method for activating macrophage using the same |
| 11/11/2008 | US7449290 Method for selecting genetically transformed cells |
| 11/11/2008 | US7449289 Methods for detection and identification of methicillin-resistant Staphylococcus aureus |
| 11/11/2008 | US7449250 Method for surface treatment of gold-plated body and surface-treated product and process for producing gold-plated body and gold-plated body, and method for immobilization of sulfur-containing molecules |
| 11/11/2008 | US7449188 Recombinant oligometric protein complexes with enhanced immunogenic potential |
| 11/11/2008 | US7449187 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease |
| 11/11/2008 | US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 11/11/2008 | US7449182 Using vascular endothelial growth factor specific immunoglobulin as tool in diagnosis, prevention and treatment of cell proliferative, respiratory, vision and inflammatory disorders |
| 11/11/2008 | US7449179 Vectors for conditional gene inactivation |
| 11/11/2008 | US7449178 Attenuated gram negative bacteria |
| 11/11/2008 | US7449176 Treatment of inflammatory bowel disease with IFN-γ inhibitors |
| 11/06/2008 | WO2008134646A2 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 11/06/2008 | WO2008134640A2 Cells expressing chimeric ns4a proteins of hcv and their use in assays |
| 11/06/2008 | WO2008134593A1 Molecular circuits |
| 11/06/2008 | WO2008134571A1 Plant co2 sensors, nucleic acids encoding them, and methods for making and using them |
| 11/06/2008 | WO2008134539A1 Fig4 gene mutations in neurodegeneration |
| 11/06/2008 | WO2008134522A1 Deriving embryonic stem cells |
| 11/06/2008 | WO2008134472A1 Compositions, methods, and devices for isolating biological materials |
| 11/06/2008 | WO2008134464A2 Sample-processing reagent compositions, methods, and devices |
| 11/06/2008 | WO2008134461A2 Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| 11/06/2008 | WO2008134372A2 Production of proanthocyanidins to improve forage quality |
| 11/06/2008 | WO2008134200A1 High efficiency electroporation buffer |
| 11/06/2008 | WO2008134072A2 Hemipteran- and coleopteran- active toxin proteins from bacillus thuringiensis |
| 11/06/2008 | WO2008134068A2 Synthetic expression vectors for insect cells |
| 11/06/2008 | WO2008134044A2 Viral vector driven mutant bacterial cytosine deaminase gene and uses thereof |
| 11/06/2008 | WO2008133772A1 Method for modulating activity of t lymphocytes |
| 11/06/2008 | WO2008133701A1 Methods and compositions for increasing replication capacity of an influenza virus |
| 11/06/2008 | WO2008133651A2 Ablative immunotherapy |
| 11/06/2008 | WO2008133643A2 Plant micrornas and methods of use thereof |
| 11/06/2008 | WO2008133511A2 Modified phosphatases |
| 11/06/2008 | WO2008133468A1 An efficiently replicable heptitis c virus mutant, a heptitis c virus mutant comprising reporter gene a method of preparing of hcv vaccine using the same and a method of screening anti hcv composition using the same |
| 11/06/2008 | WO2008133329A1 Method for evaluation of drug sensitivity by analysis of pomc gene |
| 11/06/2008 | WO2008133226A1 Novel strain of bacillus natto and soft natto produced by using the bacillus natto strain |
| 11/06/2008 | WO2008133206A1 Non-replicating paramyxoviridae virus vector |
| 11/06/2008 | WO2008133196A1 Material for regenerative medicine |
| 11/06/2008 | WO2008133161A1 Method for production of acidic substance having carboxyl group |
| 11/06/2008 | WO2008133141A1 Osmotin recombinant protein, method for production of the same, and use of the same |
| 11/06/2008 | WO2008133137A1 Vector for gene therapy |
| 11/06/2008 | WO2008133131A1 Method for production of organic acid |
| 11/06/2008 | WO2008132743A2 Production of high mannose proteins in plant culture |
| 11/06/2008 | WO2008132729A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 11/06/2008 | WO2008132568A2 Fusion proteins binding to growth factors |
| 11/06/2008 | WO2008132485A2 Mutants of interleukin- 1 receptor antagonist and uses thereof |
| 11/06/2008 | WO2008132453A1 Antibodies against ramp3 |
| 11/06/2008 | WO2008132234A2 Rna antagonist compounds for the modulation of beta-catenin |
| 11/06/2008 | WO2008132231A1 Plants having improved growth characteristics under reduced nutrient availability and a method for making the same |
| 11/06/2008 | WO2008132152A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 11/06/2008 | WO2008132134A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 11/06/2008 | WO2008131951A1 Selective targeting of viruses to neural precursor cells |
| 11/06/2008 | WO2008131913A1 Angiomotin-like protein 1-derived molecules for the modulation of angiogenesis and the treatment of tumours |
| 11/06/2008 | WO2008131905A1 Method and device for characterizing a plant sample |
| 11/06/2008 | WO2008131828A2 Putative chloroplast transporter as novel specific kanamycin resistance marker |
| 11/06/2008 | WO2008131807A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 11/06/2008 | WO2008131599A1 T-cell receptor vaccines materials and methods |
| 11/06/2008 | WO2008131580A1 Site-directed mutagenesis in circular methylated dna |
| 11/06/2008 | WO2008131552A1 Pseudopterosin-producing bacteria and methods of use |
| 11/06/2008 | WO2008115061A3 Dual targeting system |
| 11/06/2008 | WO2008113832A3 SHORT RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF TARGET mRNA |
| 11/06/2008 | WO2008112911A3 Attenuated reoviruses for selection of cell populations |
| 11/06/2008 | WO2008112787A3 Method and apparatus of low strength electric field network-mediated delivery of therapeutics in solid organs |
| 11/06/2008 | WO2008112267A3 Transformation of immature soybean seeds through organogenesis |
| 11/06/2008 | WO2008112218A3 Li-rnai involved li suppression in cancer immunotherapy |
| 11/06/2008 | WO2008112030A3 Transfection in electronically driven continuous flow |
| 11/06/2008 | WO2008109547A3 Nucleic acid compounds for inhibiting tymp gene expression and uses thereof |
| 11/06/2008 | WO2008109526B1 Nucleic acid compounds for inhibiting egr gene expression and uses thereof |
| 11/06/2008 | WO2008109518B1 Nucleic acid compounds for inhibiting wnt gene expression and uses thereof |
| 11/06/2008 | WO2008109505B1 Nucleic acid compounds for inhibiting cd22 gene expression and uses thereof |
| 11/06/2008 | WO2008109475B1 Nucleic acid compounds for inhibiting sirt2 gene expression and uses thereof |
| 11/06/2008 | WO2008109456B1 Nucleic acid compounds for inhibiting dgat gene expression and uses thereof |
| 11/06/2008 | WO2008109452B1 Nucleic acid compounds for inhibiting tie gene expression and uses thereof |
| 11/06/2008 | WO2008109364A3 Nucleic acid compounds for inhibiting frap1 gene expression and uses thereof |
| 11/06/2008 | WO2008109361B1 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof |
| 11/06/2008 | WO2008109354B1 Nucleic acid compounds for inhibiting il18 gene expression and uses thereof |
| 11/06/2008 | WO2008109353B1 Nucleic acid compounds for inhibiting map2k gene expression and uses thereof |
| 11/06/2008 | WO2008108964A3 Death associated protein kinase 1 (dapk1) and uses thereof for the treatment of chronic lymphocytic leukemia |
| 11/06/2008 | WO2008107462A3 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd) |
| 11/06/2008 | WO2008106451A3 Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease |